Older donors and kidney transplantation

Area of Science:

• Nephrology
• Transplantation immunology
• Geriatric medicine

Background:

• Concerns exist regarding the outcomes of kidney transplants using older donor organs (>50 years).
• Previous reports suggest inferior results, leading to reluctance in utilizing these kidneys.

Purpose of the Study:

• To evaluate the outcomes of kidney transplantation using donors over 50 years of age.
• To compare graft survival and function rates between older and younger kidney donors.

Main Methods:

• Retrospective review of 45 kidney transplants from donors aged >50 years.
• Comparison of primary nonfunction, immediate graft function, and 1-, 2-, and 3-year graft survival rates with a control group (donors aged 20-40 years).
• Assessment of 1-year renal function using serum creatinine levels.

Main Results:

• Graft survival rates at 1, 2, and 3 years were comparable between older and younger donor groups.
• Primary nonfunction and immediate graft function rates were similar across both donor age groups.
• One-year post-transplant renal function, indicated by serum creatinine, was poorer in recipients of kidneys from older donors.
• Cyclosporine therapy did not demonstrate a significant beneficial effect on graft survival compared to conventional immunosuppression in this cohort.

Conclusions:

• Kidneys from donors over 50 years of age are a viable and valuable resource for kidney transplantation.
• Despite slightly poorer short-term renal function, older donor kidneys offer comparable long-term graft survival.
• Further research with larger sample sizes is needed to confirm the impact of immunosuppressive regimens like cyclosporine.